This educational initiative intends to close β‑thalassemia clinical care gaps when transitioning patient care from pediatrics into adulthood

A physician and patient with obesity model a discussion on mitigating the patient’s risk for heart failure with strategies for weight loss and increased physical activity.

Identify the optimal CKD treatment option(s) based on patient clinical characteristics and benefits/risks of currently approved agents

X-linked hypophosphatemia (XLH) and hypophosphotasia (HPP) are genetic metabolic bone diseases with recent treatment advances. This program will discuss when to refer and how to treat children with XLH or HPP in the era of disease specific therapies. 

Join Dr. Amy Zack as she discusses diabetic retinopathy and emphasizes the need for eye health in patients with diabetes, how best to support patients for optimal eye health via education and screening, and Dr. Steven Ferrucci helps explain diabetic eye exams.  

This activity will review key predictors for hyperkalemia, clinical evidence for new potassium-binding agents, and the use of team-based care in rural and underserved areas.

Faculty discuss the case of a man with obesity and obstructive sleep apnea, with a focus on the interplay between the two conditions, as well as weight loss to relieve symptoms.